Artificial Intelligence (AI) Webinar
A very successful webinar on Artificial Intelligence (AI) in paediatrics took place on the 7th of December 2022.
Spotlight on a National Hub: Netherlands
As of 2017 Pedmed-NL is the Dutch network to facilitate paediatric clinical trials.
c4c Multi-Stakeholder Meeting on Paediatric type I diabetes
conect4children is pleased to announce that the third c4c International Multi-Stakeholder Meeting (MSM) will address medical devices in paediatric type I diabetes.
Involving families with preterm babies in PPI
Thanks to advances in neonatal care and technology, babies born as early as 23 weeks preterm survive at higher rates than ever before.
c4c Project Leadership Team End of Year Review
After two years of virtual meetings, as the c4c Project Leadership Team, we were pleased to see so many c4c Beneficiaries in person at the General Assembly in June in Ghent.
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children
Many medicines are used “off-label” in children outside the terms of the license. Feasible pediatric clinical trials are a challenge to design. Conect4children (c4c) is an Innovative Medicines Initiative project to set up a pan-European pediatric clinical trial network aiming to facilitate the development of new medicines for children. To optimize pediatric trial development by…
Understanding Paediatric Data Standards
To understand the challenges arising out of these principles, the c4c team at Newcastle University conducted semi-structured interviews with four c4c industry partners.
15-16 Dec: XV Foresight Training Course
SAVE THE DATE – XV Foresight Training Course (15-16 December 2022, Bari)
c4c team: Adriana Ceci
Today’s spotlight is on Adriana Ceci, who played a leading role in founding the Teddy network in Italy.
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children
Pharmacometric modelling plays a key role in both the design and analysis of regulatory trials in paediatric drug development. Studies in adults provide a rich source of data to inform the paediatric investigation plans, including knowledge on drug pharmacokinetics (PK), safety and efficacy. In children, drug disposition differs widely from birth to adolescence but extrapolating…